Security key
87978U108
Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST)
CUSIP: 87978U108
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 14,815,636
- Total 13F shares
- 3,113,726
- Share change
- +1,012,928
- Total reported value
- $6,672,000
- Price per share
- $2.14
- Number of holders
- 15
- Value change
- +$2,166,223
- Number of buys
- 5
- Number of sells
- 6
Report period
Q2 2022
Institutions
15
Top holders
10
TPST full security history
Newer quarter: Q3 2022
Previous quarter: Q1 2022
Tempest Therapeutics, Inc. SEC filings
Tempest Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 87978U108
Recent filing periods:
Top shareholders of TPST - Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Rock Springs Capital Management LP |
13F
3/4/5
|
Company · 10%+ Owner |
5.6%
|
823,654
|
$2,784,000 | — | 31 Mar 2022 | |
| FMR LLC |
13F
|
Company |
4.4%
|
647,898
|
$2,203,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.7%
|
249,088
|
$842,000 | — | 31 Mar 2022 | |
| FIL Ltd |
13F
|
Company |
0.87%
|
129,579
|
$441,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.56%
|
82,985
|
$280,000 | — | 31 Mar 2022 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.42%
|
61,827
|
$210,000 | — | 31 Mar 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.27%
|
40,193
|
$136,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.23%
|
34,521
|
$117,000 | — | 31 Mar 2022 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.11%
|
15,800
|
$54,000 | — | 31 Mar 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.07%
|
10,100
|
$34,000 | — | 31 Mar 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
2,173
|
$7,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
2,077
|
$7,000 | — | 31 Mar 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
903
|
$3,000 | — | 31 Mar 2022 | |
| Versant Vantage II, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,118,644
|
$10,127,118 | — | 29 Apr 2022 | |
| Pierre Lorenzo |
3/4/5
|
Corporate Controller |
—
class O/S missing
|
8,477
|
— | — | 21 Jun 2022 | |
| Stella Xu |
3/4/5
|
Director |
—
class O/S missing
|
6,635
|
— | — | 01 Jul 2021 | |
| Thomas Woiwode |
3/4/5
|
Director |
—
class O/S missing
|
3,500
|
— | — | 17 Jun 2022 |
Institutional Holders of Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST) as of Q2 2022
As of 30 Jun 2022,
Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,113,726 shares.
The largest 10 holders included
EcoR1 Capital, LLC, Rock Springs Capital Management LP, FMR LLC, VANGUARD GROUP INC, FIL Ltd, BlackRock Inc., Ikarian Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
15
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
13
Q2 2022 holders
15
Holder diff
2
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.